MedPath

Ipratropium Bromide

PRESCRIBING INFORMATION IPRATROPIUM BROMIDE NASAL SOLUTION, 0.03% Nasal Spray Rx Only

Approved
Approval ID

6493c00f-2306-2cb6-9624-4ea678f66576

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 18, 2025

Manufacturers
FDA

NORTHSTAR RX LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ipratropium Bromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code16714-526
Application NumberANDA076156
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ipratropium Bromide
Product Specifications
Route of AdministrationNASAL
Effective DateSeptember 18, 2025
FDA Product Classification

INGREDIENTS (7)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
IPRATROPIUM BROMIDEActive
Quantity: 21 ug in 1 1
Code: J697UZ2A9J
Classification: ACTIR
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 9/25/2024

PRINCIPAL DISPLAY PANEL - 0.03 percent Carton Label

Northstar Rx LLC NDC 16714-526-01

Ipratropium Bromide Nasal Solution, 0.03%

Nasal Spray

345 Metered Sprays

21 mcg/spray

Rx Only

![ipra-naso-0-03pct-ctn](/dailymed/image.cfm?name=ipra-naso-0-03pct- ctn.jpg&id=898506)

SPL PATIENT PACKAGE INSERT SECTION

LOINC: 42230-3Updated: 5/9/2014

PATIENT'S INSTRUCTIONS FOR USE

Ipratropium Bromide Nasal Solution, 0.03%

Nasal Spray

(ip" ra troe' pee um broe' mide)

Rx Only

Read complete instructions carefully before using.

In order to ensure proper dosing, do not attempt to change the size of the spray opening.

Ipratropium Bromide Nasal Solution, 0.03% is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. Ipratropium Bromide Nasal Solution, 0.03% does not relieve nasal congestion, sneezing or postnasal drip associated with allergic or nonallergic perennial rhinitis.

Read complete instructions carefully and use only as directed.

To Use:

1. Remove the clear plastic dust cap and the green safety clip from the nasal spray pump ( Figure 1). The safety clip prevents the accidental discharge of the spray in your pocket or purse.

fig1

Figure 1

2. The nasal spray pump must be primed before ipratropium bromide nasal solution, 0.03% is used for the first time. To prime the pump, hold the bottle with your thumb at the base and your index and middle fingers on the white shoulder area. Make sure the bottle points upright and away from your eyes. Press your thumb firmly and quickly against the bottle seven times ( Figure 2). The pump is now primed and can be used. Your pump should not have to be reprimed unless you have not used the medication for more than 24 hours; repriming the pump will only require two sprays. If you have not used your nasal spray for more than seven days, repriming the pump will require seven sprays.

fig2

Figure 2

3. Before using ipratropium bromide nasal solution, 0.03%, blow your nose gently to clear your nostrils if necessary.

4. Close one nostril by gently placing your finger against the side of your nose, tilt your head slightly forward and, keeping the bottle upright, insert the nasal tip into the other nostril ( Figure 3). Point the tip toward the back and outer side of the nose.

fig3

Figure 3

5. Press firmly and quickly upwards with the thumb at the base while holding the white shoulder portion of the pump between your index and middle fingers. Following each spray, sniff deeply and breathe out through your mouth.

6. After spraying the nostril and removing the unit, tilt your head backwards for a few seconds to let the spray spread over the back of the nose.

7. Repeat steps 4 through 6 in the same nostril.

8. Repeat steps 4 through 7 in the other nostril (i.e., two sprays per nostril).

9. Replace the clear plastic dust cap and safety clip.

10. At some time before the medication is completely used up, you should consult your physician or pharmacist to determine whether a refill is needed. You should not take extra doses or stop using ipratropium bromide nasal solution, 0.03% without consulting your physician.

To Clean:

fig4

Figure 4

If the nasal tip becomes clogged, remove the clear plastic dust cap and safety clip. Hold the nasal tip under running, warm tap water ( Figure 4) for about a minute. Dry the nasal tip, reprime the nasal spray pump (step 2 above), and replace the plastic dust cap and safety clip.

Caution

Ipratropium Bromide Nasal Solution, 0.03% is intended to relieve your rhinorrhea (runny nose) with regular use. It is therefore important that you use Ipratropium Bromide Nasal Solution, 0.03% as prescribed by your physician. For most patients, some improvement in runny nose is usually apparent during the first full day of treatment with Ipratropium Bromide Nasal Solution, 0.03%. Some patients may require up to two weeks of treatment to obtain maximum benefit.

Do not spray Ipratropium Bromide Nasal Solution, 0.03% in your eyes. Should this occur, immediately flush your eye with cool tap water for several minutes. If you accidentally spray Ipratropium Bromide Nasal Solution, 0.03% in your eyes, you may experience a temporary blurring of vision, visual halos or colored images in association with red eyes from conjunctival and corneal congestion, development or worsening of narrow-angle glaucoma, pupil dilation, or acute eye pain/discomfort, and increased sensitivity to light, which may last a few hours. Should acute eye pain or blurred vision occur, contact your doctor.

Should you experience excessive nasal dryness or episodes of nasal bleeding, contact your doctor.

If you have glaucoma or difficulty urinating due to an enlargement of the prostate, be sure to tell your physician prior to using ipratropium bromide nasal solution 0.03%. .

If you are pregnant or you are breast feeding your baby, be sure to tell your physician prior to using ipratropium bromide nasal solution 0.03%.

Address medical inquiries to Northstar Rx LLC at 1-800-206-7821.

Storage

Store tightly closed at 20°-25°C (68°-77°F) [See USP Controlled Room Temperature]. Avoid freezing. Keep out of reach of children.

Manufactured for:

Manufactured by:

Northstar Rx LLC.

Apotex Inc

Memphis, TN 38141

Toronto, Ontario

Canada M9L 1T9

December 2021

DESCRIPTION SECTION

LOINC: 34089-3Updated: 5/9/2014

DESCRIPTION

The active ingredient in ipratropium bromide nasal solution is ipratropium bromide monohydrate. It is an anticholinergic agent chemically described as 8-azoniabicyclo (3.2.1) octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide, monohydrate (endo, syn)-, (+)-: a synthetic quaternary ammonium compound, chemically related to atropine. The structural formula is:

ipratropium-structure

ipratropium bromide C20H30BrNO3•H2O

monohydrate Mol. Wt. 430.4

Ipratropium bromide is a white to off-white, crystalline substance. It is freely soluble in lower alcohols and water, existing in an ionized state in aqueous solutions, and relatively insoluble in non-polar media.

Ipratropium bromide nasal solution, 0.03% is a metered-dose, manual pump spray unit which delivers 21 mcg (70 mcL) ipratropium bromide per spray on an anhydrous basis in an isotonic, aqueous solution. It also contains the following inactive ingredients: benzalkonium chloride, edetate disodium, purified water and sodium chloride. Hydrochloric acid and/or sodium hydroxide may be added to adjust the pH to 4.5 to 4.9. Each bottle contains 345 sprays.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.